GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cyclo Therapeutics Inc (NAS:CYTHW) » Definitions » 5-Year Yield-on-Cost %

Cyclo Therapeutics (Cyclo Therapeutics) 5-Year Yield-on-Cost % : 0.00 (As of May. 02, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Cyclo Therapeutics 5-Year Yield-on-Cost %?

Cyclo Therapeutics's yield on cost for the quarter that ended in Dec. 2023 was 0.00.


The historical rank and industry rank for Cyclo Therapeutics's 5-Year Yield-on-Cost % or its related term are showing as below:



CYTHW's 5-Year Yield-on-Cost % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.12
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of Cyclo Therapeutics's 5-Year Yield-on-Cost %

For the Drug Manufacturers - Specialty & Generic subindustry, Cyclo Therapeutics's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cyclo Therapeutics's 5-Year Yield-on-Cost % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cyclo Therapeutics's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Cyclo Therapeutics's 5-Year Yield-on-Cost % falls into.



Cyclo Therapeutics 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Cyclo Therapeutics is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Cyclo Therapeutics  (NAS:CYTHW) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Cyclo Therapeutics 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Cyclo Therapeutics's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Cyclo Therapeutics (Cyclo Therapeutics) Business Description

Traded in Other Exchanges
Address
6714 North West 16th Street, Suite B, Gainesville, FL, USA, 32653
Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company develops cyclodextrin-based products for the treatment of disease. Its drug candidate, Trappsol Cyclo, treats Niemann-Pick Type C disease (NPC). Its other products include Trappsol HPB, Trappsol Fine Chemical, and Aquaplex.

Cyclo Therapeutics (Cyclo Therapeutics) Headlines

From GuruFocus